At a Glance
| Eszopiclone | Gaboxadol | |
|---|---|---|
| Class | Hallucinogens, Depressant, Hypnotic | Hallucinogens, Depressant |
| Common Dose (oral) | 2–3 mg | 15–30 mg |
| Total Duration | 0.8–2.1 hrs | 1.5–3.6 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Eszopiclone and Gaboxadol is classified as dangerous. Combined CNS depression; risk of respiratory failure
Eszopiclone, a Hallucinogens, Depressant, Hypnotic, and Gaboxadol, a Hallucinogens, Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Eszopiclone is classified as a Hallucinogens, Depressant, Hypnotic while Gaboxadol is a Hallucinogens, Depressant, meaning they approach altered states through different pharmacological mechanisms. They share 8 documented effects in common, with 18 effects unique to Eszopiclone and 38 unique to Gaboxadol. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Eszopiclone | Gaboxadol | |
|---|---|---|
| Class | Hallucinogens, Depressant, Hypnotic | Hallucinogens, Depressant |
| Common Dose (oral) | 2–3 mg | 15–30 mg |
| Total Duration | 0.8–2.1 hrs | 1.5–3.6 hrs |
| Routes | oral | oral |
| Effects | 26 documented | 46 documented |
| Interaction | Dangerous | |
| Level | Eszopiclone | Gaboxadol |
|---|---|---|
| Threshold | 0.5 mg | 5 mg |
| Light | 1–1.5 mg | 10–15 mg |
| Common | 2–3 mg | 15–30 mg |
| Strong | 4–5 mg | 30–45 mg |
| Heavy | 6 mg | 45 mg |
Eszopiclone
Gaboxadol
Combined CNS depression; risk of respiratory failure